ON MONDAY, SEPTEMBER 20TH, C3 SUMMIT INTERNATIONAL, in collaboration
with the U.S. Department of State; United Nations; and the U.S.
Chamber of Commerce, cordially Invites you to attend the 11TH ANNUAL
C3 US-ARAB HEALTHCARE & BUSINESS SUMMIT: _"THE IMPACT OF INNOVATION,
INVESTMENT AND GLOBAL COOPERATION ON HEALTHCARE & BUSINESS"_Never
before has a C3 US-Arab Healthcare & Business Summit been so timely.
The 2021 conference will address the many new opportunities in lessons
learned from the pandemic in business, science, healthcare, big data,
cancer, community trends, telemedicine and more.
Don't miss this unique opportunity to hear from specialists in many of
the world's leading healthcare institutions and government
organizations. With a "netcast" reach of more than 3 million potential
global viewers, and more than 500 attendees from over 53 countries, we
definitely anticipate another epic C3 Summit. So act now!
THE C3 US-ARAB HEALTHCARE & BUSINESS SUMMIT IS HONORED TO ALSO
ANNOUNCE THE:
_2021 "C3 GLOBAL HUMANITARIAN AWARD"_ RECIPIENT:
AMBASSADOR, DR. DEBORAH L. BIRX, WHITE HOUSE CORONAVIRUS TASK FORCE
(RETIRED)
MONDAY, SEPTEMBER 20, 2021
GENERAL SESSION AGENDA (SPEAKERS & SESSIONS SUBJECT TO CHANGE):
7:30-8:15AM: REGISTRATION & CONTINENTAL BREAKFAST
8:15-9:00AM: "AUTISM IN THE MIDDLE EAST"
_PANEL MODERATOR: MR. JOHN PAYNE, PURELIFE_
9:00-9:15 AM: SUMMIT CHAIR:
DR GHASSAN ABOU-ALFA, MEMORIAL SLOAN KETTERING CANCER CENTER, USA
WELCOMING REMARKS:_"A NEW NORM AND A NEW WORLD ORDER"_
MR. HADI AL ALAWI , CHAIRMAN, CEO AND FOUNDER OF AL HAYAT GROUP
9:15-10:00 AM: KEYNOTE ADDRESS:
_"LESSONS LEARNED FROM CONFRONTING PANDEMICS GLOBALLY AND COVID19
DOMESTICALLY"_
KEYNOTE SPEAKER:
AMBASSADOR, DR. DEBORAH L. BIRX, WHITE HOUSE CORONAVIRUS TASK FORCE
(RETIRED) & 2021 "C3 HUMANITARIAN AWARD" RECIPIENT
Dr. Deborah L. Birx, MD is a world-renowned physician scientists and
expert on HIV/AIDS and infectious diseases and a diplomat who served
as a special representative for global health diplomacy. Most
recently, Dr. Birx served on the White House Coronavirus Task Force
from Mar. 2020 to Jan. 2021. Her four-decade-long career has focused
on HIV/AIDS, TB/HIV, immunology, vaccine research, global pandemics
and global health. As the U.S. Global AIDS Coordinator for presidents
Barack Obama and Donald Trump, Dr. Birx oversaw the implementation of
the 6 B/yr U.S. President's Emergency Plan for AIDS Relief (PEPFAR),
the largest commitment by any nation to combat a single disease in
history, as well as all U.S. government engagement with the Global
Fund to Fight AIDS, Tuberculosis, and Malaria. Serving as the U.S.
Special Representative for Global Health Diplomacy, she aligned the
U.S. Government's diplomacy with foreign assistance programs that
address global health challenges and accelerate progress toward
achieving an AIDS-free generation; ending preventable child and
maternal deaths; and preventing, detecting, and responding to
infectious disease threats.
In 1980, Dr. Birx began her career with the Department of Defense
(DoD) first as a Medical Resident in Internal Medicine, Fellow in
Clinical Immunology and then as a military-trained clinician in
immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she
served as an Assistant Chief of the Hospital Immunology Service at
Walter Reed Army Medical Center. Through her professionalism and
leadership in the field, she served as the Director of the U.S.
Military HIV Research Program (USMHRP) at the Walter Reed Army
Institute of Research from 1996-2005. Dr. Birx began and led one of
the most influential HIV vaccine trials in history (known as RV 144,
or the Thai trial), which provided the first supporting evidence of
any vaccine's potential effectiveness in preventing HIV infection.
During this time, she also rose to the rank of Colonel, bringing
together the Navy, Army, and Air Force in a new model of cooperation -
increasing the efficiency and effectiveness of the U.S. military's
HIV/AIDS efforts through inter-and intra-agency collaboration. Then
known as Colonel Birx, she was awarded two prestigious U.S.
Meritorious Service Medals and the Legion of Merit Award for her
groundbreaking research, leadership and management skills during her
tenure at DoD.
From 2005-2014, Dr. Birx served as the Director of the Centers for
Disease Control and Prevention's (CDC) Division of Global HIV/AIDS
(DGHA) in the CDC Center for Global Health. As DGHA Director, she
utilized her leadership ability, superior technical skills, and
passion to achieve tremendous health impact. She successfully led the
implementation of CDC's PEPFAR programs around the world and managed
an annual budget of more than $1.5 billion. Dr. Birx was responsible
for all of the agency's global HIV/AIDS activities, including
providing oversight to more than 400 staff at headquarters, over 1,500
staff in the field, and more than 45 country and regional offices in
Africa, Asia, the Caribbean, and Latin America. Recognized for her
distinguished and dedicated commitment to building local capacity and
strengthening quality laboratory health services and systems in
Africa, in 2011, Dr. Birx received a Lifetime Achievement Award from
the African Society for Laboratory Medicine. In 2014, CDC honored her
leadership in advancing the agency's HIV/AIDS response with the highly
prestigious William C. Watson, Jr. Medal of Excellence, the highest
honor bestowed by the CDC.
Dr. Birx received her medical degree from the Hershey School of
Medicine, Pennsylvania State University. She trained in internal
medicine and basic and clinical immunology at the Walter Reed Army
Medical Center and the National Institutes of Health. Dr. Birx is
board certified in internal medicine, allergy and immunology, and
diagnostic and clinical laboratory immunology. She has published over
240 manuscripts in peer-reviewed journals, authored nearly a dozen
chapters in scientific publications, as well as developed and patented
vaccines. She has received multiple awards for her work.
10:10-11:10 AM: _"KINGDOM OF SAUDI ARABIA: CREATING A NEW GLOBAL
BENCHMARK IN COMMUNITY HEALTHCARE"_
_ONE-ON-ONE INTERVIEW: DR. MALIHA HASHMI, PROMINENT HEALTH LEADER,
KINGDOM OF SAUDI ARABIA; ONE OF TOP SEVEN FEMALE HEALTH LEADERS, MENA
REGION_
The Kingdom of Saudi Arabia is about building the first cognitive
healthcare system, where world-class technology is fueled with data
and intelligence to interact seamlessly with its population, so that
health and well-being can be integrated into a holistic lifestyle. KSA
will establish a new benchmark toward a culture shift of proactive
prevention, with medical intervention as needed, all powered by the
latest technologies. In order to provide this state-of-the art
healthcare, KSA has built its holistic healthcare vision around five
global benchmarks of health and wellbeing: mental, physical, virtual,
social, and emotional support.
11:20-12:20 PM:_"THE ROLE OF BIG DATA/IOT IN PUBLIC HEALTHCARE AND
EMERGENCY PREPAREDNESS INCLUDING ENERGY & DEFENSE"_
_PANEL MODERATOR: DR. RABI HANNA, DIRECTOR OF THE PEDIATRIC BONE
MARROW TRANSPLANTATION, DEPARTMENT OF PEDIATRIC HEMATOLOGY AND
ONCOLOGY, CLEVELAND CLINIC CHILDRENS HOSPITAL, USA_
_MR. PAUL DOHERTY, PRESIDENT & CEO, IFMA FELLOW, DFC SENIOR FELLOW,
TDG - THE DIGIT GROUP, INC._
There has been plenty of press and opinions of the future of
healthcare and the role wellness plays into creating this future. The
numerous descriptions of things like Digital Twins, Blockchain,
Telemedicine and other emerging technologies can create an anxiety
among practitioners, researchers, administrators, and institutions
that entered an industry and community with a very traditional
approach to assist patients, clients and guests that now has to face
digital transformation as part of their reality.
Join us for an exploration of our industrys new reality that includes
how you and our industrys people acknowledge and adapt to digital
transformation, prepare for the sea change in value recognition, and
position ourselves for success. Our healthcare/wellness industry is
colliding with the world of technology, entertainment, and the built
environment at a rapid pace. Our panel will provide insights into how
best to position your role in the future of the healthcare and
wellness industry.
12:30-2:00 PM LUNCH & KEYNOTE SPEAKER:_"PROTECTING & BUILDING A LEGACY
OF KNOWLEDGE TRANSFER"_
_C3 2021 LEADERSHIP AWARD PRESENTATION_
As an avenue to cementing bilateral relations, the _C3 LEADERSHIP
AWARD _recognizes the importance of an individual's initiatives and
interests based on social and commercial diplomacy, thereby making an
invaluable, enduring contribution to both their country and global
community.
With these personal achievements in mind, and a focus on increasing
commercial ties between the US and the Arab world, from the personal
interchange that it involves to the mutual economic interests that it
develops, leadership is critical to encouraging dialogue and
imagination, in order to explore new opportunities that will grow
regional and global prosperity. The end result will pave the path to
increased progress for economic engagement between all global markets.
2:00-3:00 PM:_"THE PANDEMIC'S IMPACT ON CURRENT & FUTURE GLOBAL
HEALTHCARE"_
_PANEL MODERATOR: DR. MAAN FARES, MD, VICE CHAIRMAN, GLOBAL PATIENT
SERVICES, THE CLEVELAND CLINIC_
_DR. GABI HANNA, MD, EXECUTIVE DIRECTOR, DUKE TRANSLATIONAL RESEARCH
UNIT; ASSOCIATE DIRECTOR, DUKE CANCER INSTITUTE, SURGICAL FACILITY;
VP, AMERICAN REMOTE HEALTH, USA_
_DR. NURELDIN SATTI, AMBASSADOR TO THE UNITED STATES, SUDANESE
EMBASSY, WASHINGTON, DC, SUDAN_
_DR GHASSAN ABOU-ALFA, MEMORIAL SLOAN KETTERING CANCER CENTER, USA_
The pandemic's disruptions to the healthcare industry were immediate
and acute. While U.S. hospitals usually have plans for dealing with
mass casualties and natural disasters, few had contemplated, much less
planned for, the arrival of a global pandemic that was the biggest
threat to American lives since the 1918 Spanish flu. One of the most
immediate disruptions was the collapse of supply lines for personal
protective equipment (PPE). The industry learned that it had too
significant a reliance on a supply chain based in just one part of the
world, i.e. China. Another challenge was finding the space and beds to
accommodate the influx of COVID-19 patients, but an even greater
problem was staffing those beds. Also unexpected was the impact on
America's healthcare workers and the amount of misinformation and
conflicting messaging they were asked to address, which left people
unsure of whom to listen and how to protect themselves from the virus.
Finally, with all the unfortunate disruptions, there was the one most
welcomed disruption: record setting vaccine discoveries and
distributions to the global population. Also, the pandemic pushed
healthcare systems into an arena previously occupied primarily by
government and local health departments: public health. When
healthcare systems provided drive-through testing facilities, created
web-based symptom checkers or call centers so people could ask
questions about the virus, launched vaccine clinics, or advised
schools and businesses about how to safely reopen, they were providing
public health services.
3:10-4:10 PM:_"TELEMEDICINE: GLOBAL TRENDS IN A NEW NORM"_
_PANEL MODERATOR: CYNTHIA GONZALEZ, EXECUTIVE DIRECTOR OF THE
INTERNATIONAL PATIENT SERVICES PROGRAM AT COOK CHILDRENS HEALTH CARE
SYSTEM_
The most lasting new healthcare norm promoted by the global pandemic
is likely to be telemedicine. Before the coronavirus, the publics
response to the idea of visiting a doctor via computer or cell phone
was lukewarm at best, and neither Medicare nor private health
insurance companies were interested in covering such visits. But when
the pandemic hit, people adopted telehealth out of necessity. Same
thing for providers. They needed to see their patients and
telemedicine became the safest and the most efficient way to provide
remote healthcare. As a result, the pandemic led the way for
government and insurance companies to recognize and pay for telehealth
for patients.
4:20-5:20 PM:_"__CANCER PREVENTION AND TREATMENT: PATIENT CENTERED
CARE DELIVERY AND CUTTING-EDGE PERSONALIZED THERAPIES"_
_PANEL MODERATOR: MR ROBERT STEVEN KRAMARZ, FOUNDER & EXECUTIVE
DIRECTOR, JERICHO PROJECT & INTELLIVERSITY, USA _
Health systems are still working on developing and adopting patient
centered care and personalized therapies that will be necessary to
facilitate the widespread utilization of personalized medicine, which
differs significantly from the one-size-fits-all approaches to health
care that have dominated medicine for most of human history. Guided by
this patient centered care, physicians have begun to embrace a new way
of treating cancer patients called personalized medicine. Also
referred to as precision medicine, this evolving field involves the
use of diagnostic tests to determine which personalized therapies will
work best for each patient. By combining the data from those tests
with an individuals medical history, circumstances, and values, health
care providers can develop targeted approaches to cancer prevention
and treatments.
5:20-5:40 PM: CLOSING REMARKS
5:45-7:00 PM: NETWORKING RECEPTION & REMARKS
DR. MARK A. DAVIS MD, MS, ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE,
HARVARD MEDICAL SCHOOL, USA
music
588
Views
21/09/2021 Last update